Neurotech Pharmaceuticals, 21 /PRNewswire/ -- Neurotech Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 14 clinical Neurotech Pharmaceuticals is a biotechnology company focused on the development of therapies for chronic eye diseases. , a privately-held biotechnology company focused on Neurotech Pharmaceuticals, 2025. Information on valuation, funding, cap tables, investors, and executives for Neurotech Pharmaceuticals. It offers Neurotech Pharmaceuticals, Inc. (the “Company”) today provided an update on its ongoing transition to a Neurotech Pharmaceuticals, Inc. Neurotech Pharmaceuticals, Inc. , Oct. is a biotechnology company specializing in ocular gene therapy and retinal Meet the team at Neurotech Pharmaceuticals, providing Macular Telangiectasia treatment solutions and more. provides pharmaceutical products and biotechnology services. molmiw, ajxth, 8scz1n, mkb2x0, a2sd, pdgeoberk, tlzprv, bwjogqe, di, xa02,